Cargando…
Seroprevalence, Waning and Correlates of Anti-SARS-CoV-2 IgG Antibodies in Tyrol, Austria: Large-Scale Study of 35,193 Blood Donors Conducted between June 2020 and September 2021
There is uncertainty about the seroprevalence of anti-SARS-CoV-2 antibodies in the general population of Austria and about the waning of antibodies over time. We conducted a seroepidemiological study between June 2020 and September 2021, enrolling blood donors aged 18–70 years across Tyrol, Austria...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954543/ https://www.ncbi.nlm.nih.gov/pubmed/35336975 http://dx.doi.org/10.3390/v14030568 |
_version_ | 1784676119159504896 |
---|---|
author | Siller, Anita Seekircher, Lisa Wachter, Gregor A. Astl, Manfred Tschiderer, Lena Pfeifer, Bernhard Gaber, Manfred Schennach, Harald Willeit, Peter |
author_facet | Siller, Anita Seekircher, Lisa Wachter, Gregor A. Astl, Manfred Tschiderer, Lena Pfeifer, Bernhard Gaber, Manfred Schennach, Harald Willeit, Peter |
author_sort | Siller, Anita |
collection | PubMed |
description | There is uncertainty about the seroprevalence of anti-SARS-CoV-2 antibodies in the general population of Austria and about the waning of antibodies over time. We conducted a seroepidemiological study between June 2020 and September 2021, enrolling blood donors aged 18–70 years across Tyrol, Austria (participation rate: 84.0%). We analyzed serum samples for antibodies against the spike or the nucleocapsid proteins of SARS-CoV-2. We performed a total of 47,363 samples taken from 35,193 individuals (median age, 43.1 years (IQR: 29.3–53.7); 45.3% women; 10.0% with prior SARS-CoV-2 infection). Seroprevalence increased from 3.4% (95% CI: 2.8–4.2%) in June 2020 to 82.7% (95% CI: 81.4–83.8%) in September 2021, largely due to vaccination. Anti-spike IgG seroprevalence was 99.6% (95% CI: 99.4–99.7%) among fully vaccinated individuals, 90.4% (95% CI: 88.8–91.7%) among unvaccinated individuals with prior infection and 11.5% (95% CI: 10.8–12.3%) among unvaccinated individuals without known prior infection. Anti-spike IgG levels were reduced by 44.0% (95% CI: 34.9–51.7%) at 5–6 months compared with 0–3 months after infection. In fully vaccinated individuals, they decreased by 31.7% (95% CI: 29.4–33.9%) per month. In conclusion, seroprevalence in Tyrol increased to 82.7% in September 2021, with the bulk of seropositivity stemming from vaccination. Antibody levels substantially and gradually declined after vaccination or infection. |
format | Online Article Text |
id | pubmed-8954543 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89545432022-03-26 Seroprevalence, Waning and Correlates of Anti-SARS-CoV-2 IgG Antibodies in Tyrol, Austria: Large-Scale Study of 35,193 Blood Donors Conducted between June 2020 and September 2021 Siller, Anita Seekircher, Lisa Wachter, Gregor A. Astl, Manfred Tschiderer, Lena Pfeifer, Bernhard Gaber, Manfred Schennach, Harald Willeit, Peter Viruses Article There is uncertainty about the seroprevalence of anti-SARS-CoV-2 antibodies in the general population of Austria and about the waning of antibodies over time. We conducted a seroepidemiological study between June 2020 and September 2021, enrolling blood donors aged 18–70 years across Tyrol, Austria (participation rate: 84.0%). We analyzed serum samples for antibodies against the spike or the nucleocapsid proteins of SARS-CoV-2. We performed a total of 47,363 samples taken from 35,193 individuals (median age, 43.1 years (IQR: 29.3–53.7); 45.3% women; 10.0% with prior SARS-CoV-2 infection). Seroprevalence increased from 3.4% (95% CI: 2.8–4.2%) in June 2020 to 82.7% (95% CI: 81.4–83.8%) in September 2021, largely due to vaccination. Anti-spike IgG seroprevalence was 99.6% (95% CI: 99.4–99.7%) among fully vaccinated individuals, 90.4% (95% CI: 88.8–91.7%) among unvaccinated individuals with prior infection and 11.5% (95% CI: 10.8–12.3%) among unvaccinated individuals without known prior infection. Anti-spike IgG levels were reduced by 44.0% (95% CI: 34.9–51.7%) at 5–6 months compared with 0–3 months after infection. In fully vaccinated individuals, they decreased by 31.7% (95% CI: 29.4–33.9%) per month. In conclusion, seroprevalence in Tyrol increased to 82.7% in September 2021, with the bulk of seropositivity stemming from vaccination. Antibody levels substantially and gradually declined after vaccination or infection. MDPI 2022-03-09 /pmc/articles/PMC8954543/ /pubmed/35336975 http://dx.doi.org/10.3390/v14030568 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Siller, Anita Seekircher, Lisa Wachter, Gregor A. Astl, Manfred Tschiderer, Lena Pfeifer, Bernhard Gaber, Manfred Schennach, Harald Willeit, Peter Seroprevalence, Waning and Correlates of Anti-SARS-CoV-2 IgG Antibodies in Tyrol, Austria: Large-Scale Study of 35,193 Blood Donors Conducted between June 2020 and September 2021 |
title | Seroprevalence, Waning and Correlates of Anti-SARS-CoV-2 IgG Antibodies in Tyrol, Austria: Large-Scale Study of 35,193 Blood Donors Conducted between June 2020 and September 2021 |
title_full | Seroprevalence, Waning and Correlates of Anti-SARS-CoV-2 IgG Antibodies in Tyrol, Austria: Large-Scale Study of 35,193 Blood Donors Conducted between June 2020 and September 2021 |
title_fullStr | Seroprevalence, Waning and Correlates of Anti-SARS-CoV-2 IgG Antibodies in Tyrol, Austria: Large-Scale Study of 35,193 Blood Donors Conducted between June 2020 and September 2021 |
title_full_unstemmed | Seroprevalence, Waning and Correlates of Anti-SARS-CoV-2 IgG Antibodies in Tyrol, Austria: Large-Scale Study of 35,193 Blood Donors Conducted between June 2020 and September 2021 |
title_short | Seroprevalence, Waning and Correlates of Anti-SARS-CoV-2 IgG Antibodies in Tyrol, Austria: Large-Scale Study of 35,193 Blood Donors Conducted between June 2020 and September 2021 |
title_sort | seroprevalence, waning and correlates of anti-sars-cov-2 igg antibodies in tyrol, austria: large-scale study of 35,193 blood donors conducted between june 2020 and september 2021 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954543/ https://www.ncbi.nlm.nih.gov/pubmed/35336975 http://dx.doi.org/10.3390/v14030568 |
work_keys_str_mv | AT silleranita seroprevalencewaningandcorrelatesofantisarscov2iggantibodiesintyrolaustrialargescalestudyof35193blooddonorsconductedbetweenjune2020andseptember2021 AT seekircherlisa seroprevalencewaningandcorrelatesofantisarscov2iggantibodiesintyrolaustrialargescalestudyof35193blooddonorsconductedbetweenjune2020andseptember2021 AT wachtergregora seroprevalencewaningandcorrelatesofantisarscov2iggantibodiesintyrolaustrialargescalestudyof35193blooddonorsconductedbetweenjune2020andseptember2021 AT astlmanfred seroprevalencewaningandcorrelatesofantisarscov2iggantibodiesintyrolaustrialargescalestudyof35193blooddonorsconductedbetweenjune2020andseptember2021 AT tschidererlena seroprevalencewaningandcorrelatesofantisarscov2iggantibodiesintyrolaustrialargescalestudyof35193blooddonorsconductedbetweenjune2020andseptember2021 AT pfeiferbernhard seroprevalencewaningandcorrelatesofantisarscov2iggantibodiesintyrolaustrialargescalestudyof35193blooddonorsconductedbetweenjune2020andseptember2021 AT gabermanfred seroprevalencewaningandcorrelatesofantisarscov2iggantibodiesintyrolaustrialargescalestudyof35193blooddonorsconductedbetweenjune2020andseptember2021 AT schennachharald seroprevalencewaningandcorrelatesofantisarscov2iggantibodiesintyrolaustrialargescalestudyof35193blooddonorsconductedbetweenjune2020andseptember2021 AT willeitpeter seroprevalencewaningandcorrelatesofantisarscov2iggantibodiesintyrolaustrialargescalestudyof35193blooddonorsconductedbetweenjune2020andseptember2021 |